Search Results - "ALBERT, Gary"

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine by Keech, Cheryl, Albert, Gary, Cho, Iksung, Robertson, Andreana, Reed, Patricia, Neal, Susan, Plested, Joyce S, Zhu, Mingzhu, Cloney-Clark, Shane, Zhou, Haixia, Smith, Gale, Patel, Nita, Frieman, Matthew B, Haupt, Robert E, Logue, James, McGrath, Marisa, Weston, Stuart, Piedra, Pedro A, Desai, Chinar, Callahan, Kathleen, Lewis, Maggie, Price-Abbott, Patricia, Formica, Neil, Shinde, Vivek, Fries, Louis, Lickliter, Jason D, Griffin, Paul, Wilkinson, Bethanie, Glenn, Gregory M

“…A recombinant SARS-CoV-2 spike protein nanoparticle vaccine delivered in the deltoid muscle on days 0 and 21 was found to be immunogenic at both 5 μg and 25 μg…”
Get full text

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial by Formica, Neil, Mallory, Raburn, Albert, Gary, Robinson, Michelle, Plested, Joyce S, Cho, Iksung, Robertson, Andreana, Dubovsky, Filip, Glenn, Gregory M

“…Background NVX-CoV2373 is a recombinant severe acute respiratory coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2…”
Get full text

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine by Heath, Paul T, Galiza, Eva P, Baxter, David N, Boffito, Marta, Browne, Duncan, Burns, Fiona, Chadwick, David R, Clark, Rebecca, Cosgrove, Catherine, Galloway, James, Goodman, Anna L, Heer, Amardeep, Higham, Andrew, Iyengar, Shalini, Jamal, Arham, Jeanes, Christopher, Kalra, Philip A, Kyriakidou, Christina, McAuley, Daniel F, Meyrick, Agnieszka, Minassian, Angela M, Minton, Jane, Moore, Patrick, Munsoor, Imrozia, Nicholls, Helen, Osanlou, Orod, Packham, Jonathan, Pretswell, Carol H, San Francisco Ramos, Alberto, Saralaya, Dinesh, Sheridan, Ray P, Smith, Richard, Soiza, Roy L, Swift, Pauline A, Thomson, Emma C, Turner, Jeremy, Viljoen, Marianne E, Albert, Gary, Cho, Iksung, Dubovsky, Filip, Glenn, Greg, Rivers, Joy, Robertson, Andreana, Smith, Kathy, Toback, Seth

“…In a phase 3 trial involving more than 15,000 participants, two doses of NVX-CoV2373, a recombinant SARS-CoV-2 nanoparticle vaccine, administered 21 days apart…”
Get full text

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis by Khalil, Nasreen, Manganas, Helene, Ryerson, Christopher J, Shapera, Shane, Cantin, Andre M, Hernandez, Paul, Turcotte, Eric E, Parker, Joseph M, Moran, John E, Albert, Gary R, Sawtell, Renata, Hagerimana, Aline, Laurin, Pierre, Gagnon, Lyne, Cesari, Frank, Kolb, Martin

“…PBI-4050 is a novel orally active small-molecule compound with demonstrated anti-fibrotic activity in several models of fibrosis, including lung fibrosis. We…”
Get full text

Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency by Shapiro, Amy D., Nakar, Charles, Parker, Joseph M., Albert, Gary R., Moran, John E., Thibaudeau, Karen, Thukral, Neelam, Hardesty, Brandon M., Laurin, Pierre, Sandset, Per Morten

“…Congenital plasminogen deficiency is caused by mutations in PLG, the gene coding for production of the zymogen plasminogen, and is an ultrarare disorder…”
Get full text

Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer by MANEGOLD, Christian, GRAVENOR, Donald, WOYTOWITZ, Donald, MEZGER, Jörg, HIRSH, Vera, ALBERT, Gary, AL-ADHAMI, Mohammed, READETT, David, KRIEG, Arthur M, GAIL LEICHMAN, Cynthia

“…This study assessed the efficacy of the combination of standard taxane plus platinum chemotherapy with the synthetic Toll-like receptor 9-activating…”
Get full text

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant by Shinde, Vivek, Bhikha, Sutika, Hoosain, Zaheer, Archary, Moherndran, Bhorat, Qasim, Fairlie, Lee, Lalloo, Umesh, Masilela, Mduduzi S.L, Moodley, Dhayendre, Hanley, Sherika, Fouche, Leon, Louw, Cheryl, Tameris, Michele, Singh, Nishanta, Goga, Ameena, Dheda, Keertan, Grobbelaar, Coert, Kruger, Gertruida, Carrim-Ganey, Nazira, Baillie, Vicky, de Oliveira, Tulio, Lombard Koen, Anthonet, Lombaard, Johan J, Mngqibisa, Rosie, Bhorat, As’ad E, Benadé, Gabriella, Lalloo, Natasha, Pitsi, Annah, Vollgraaff, Pieter-Louis, Luabeya, Angelique, Esmail, Aliasgar, Petrick, Friedrich G, Oommen-Jose, Aylin, Foulkes, Sharne, Ahmed, Khatija, Thombrayil, Asha, Fries, Lou, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S, Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M, Dubovsky, Filip, Madhi, Shabir A

“…A randomized, phase 2 trial compared the NVX-CoV2373 nanoparticle vaccine with placebo in participants in South Africa, including 30% who were seropositive at…”
Get full text

Trademark law by Albert, Gary

Get full text

CORRESPONDENCE by Albert, Gary

Get full text

Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial by Mallory, Raburn M, Formica, Neil, Pfeiffer, Susan, Wilkinson, Bethanie, Marcheschi, Alex, Albert, Gary, McFall, Heather, Robinson, Michelle, Plested, Joyce S, Zhu, Mingzhu, Cloney-Clark, Shane, Zhou, Bin, Chau, Gordon, Robertson, Andreana, Maciejewski, Sonia, Hammond, Holly L, Baracco, Lauren, Logue, James, Frieman, Matthew B, Smith, Gale, Patel, Nita, Glenn, Gregory M, Adams, Mark, Arya, Mark, Athan, Eugene, Berger, Ira, Bradley, Paul, Briskin, Toby, Glover II, Richard, Griffin, Paul, Kim, Joshua, Kitchener, Scott, Klein, Terry, Leah, Amber, Leelasena, Indika, Lemech, Charlotte, Lickliter, Jason, Manning, Mary Beth, Napier-Flood, Fiona, Nugent, Paul, Thackwray, Susan, Turner, Mark

“…Emerging SARS-CoV-2 variants and evidence of waning vaccine efficacy present substantial obstacles towards controlling the COVID-19 pandemic. Booster doses of…”
Get full text

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine by Formica, Neil, Mallory, Raburn, Albert, Gary, Robinson, Michelle, Plested, Joyce S, Cho, Iksung, Robertson, Andreana, Dubovsky, Filip, Glenn, Gregory M

“…Background NVX-CoV2373 is a recombinant severe acute respiratory coronavirus 2 (rSARS-CoV-2) nanoparticle vaccine composed of trimeric full-length SARS-CoV-2…”
Get full text

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus by ZAMORA, Martin R, BUDEV, Marie, GOLLOB, Jared A, GLANVILLE, Allan R, ROLFE, Mark, GOTTLIEB, Jens, HUMAR, Atul, DEVINCENZO, John, VAISHNAW, Akshay, CEHELSKY, Jeffrey, ALBERT, Gary, NOCHUR, Sara

“…Lower respiratory tract infections due to respiratory syncytial virus (RSV) are associated with development of bronchiolitis obliterans syndrome in lung…”
Get full text

Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination by Fries, Louis, Formica, Neil, Mallory, Raburn M, Zhou, Haixia, Plested, Joyce S, Kalkeri, Raj, Moldovan, Ioana, Patel, Nita, Albert, Gary, Robinson, Michelle, Cho, Iksung, Chau, Gordon, Dubovsky, Filip, Glenn, Gregory M

“…Abstract Background NVX-CoV2373 is an efficacious coronavirus disease 2019 (COVID-19) vaccine comprising full-length recombinant severe acute respiratory…”
Get full text

Computer Modeling Using Historical Data Demonstrates a Significant Reduction in Expected Extravascular Fibrinous Lesions Due to Congenital Plasminogen Deficiency While Receiving Intravenous Plasminogen (PLG) Replacement by Parker, Joseph M, Craig, Danielle, Gaido, Marcia, Albert, Gary, Monseur, Arnaud, Shapiro, Amy D., Moran, John

“…Background: Congenital plasminogen deficiency (PLGD) caused by mutations in the PLG gene is a rare disorder associated with extravascular fibrinous deposits on…”
Get full text

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial by Madhi, Shabir A, Moodley, Dhayendre, Hanley, Sherika, Archary, Moherndran, Hoosain, Zaheer, Lalloo, Umesh, Louw, Cheryl, Fairlie, Lee, Fouche, Leon Frederik, Masilela, Mduduzi S L, Singh, Nishanta, Grobbelaar, Coert, Ahmed, Khatija, Benadé, Gabriella, Bhikha, Sutika, Bhorat, As'ad Ebrahim, Bhorat, Qasim, Joseph, Natasha, Dheda, Keertan, Esmail, Aliasgar, Foulkes, Sharne, Goga, Ameena, Oommen Jose, Aylin, Kruger, Gertruida, Kalonji, Dishiki J, Lalloo, Natasha, Lombaard, Johan J, Lombard Koen, Anthonet, Kany Luabeya, Angelique, Mngqibisa, Rosie, Petrick, Friedrich G, Pitsi, Annah, Tameris, Michele, Thombrayil, Asha, Vollgraaff, Pieter-Louis, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S, Fries, Lou, Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M, Shinde, Vivek

“…There is a paucity of data on COVID-19 vaccines in people living with HIV-1, who could be at increased risk of severe illness and death from COVID-19. We…”
Get full text

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions by Nakar, Charles T, Parker, Joseph M, Thakral, Neelam, Hardesty, Brandon M., Albert, Gary, Laurin, Pierre, Moran, John, Sandset, Per Morten, Shapiro, Amy D.

“…Background: Congenital plasminogen deficiency (PLGD) caused by mutations in the PLG gene is a rare genetic disorder that leads to clinical manifestations due…”
Get full text

Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 SARS-CoV-2 Primary Vaccination by Fries, Louis, Formica, Neil, Mallory, Raburn M, Zhou, Haixia, Plested, Joyce S, Kalkeri, Raj, Moldovan, Ioana, Patel, Nita, Albert, Gary, Robinson, Michelle, Cho, Iksung, Chau, Gordon, Dubovsky, Filip, Glenn, Gregory M

“…NVX-CoV2373 is an efficacious COVID-19 vaccine comprising full-length 5-µg recombinant SARS-CoV-2 spike (rS) glycoprotein and Matrix-M™ adjuvant. Phase 2 of a…”
Get full text

Sal Si Puedes / (Get Out If You Can) by Garay, Gary Albert

“…This project is an exploration of the aesthetics of the subaltern and how I am abstracting and deploying these ideas in my work. In my practice, I invert and…”
Get full text

Self-disclosure as an exchange process by Worthy, Morgan, Gary, Albert L, Kahn, Gay M

“…Found the exchange of self-disclosures in a laboratory setting to function in a manner consistent with social exchange theory. The intimacy of disclosures…”
Get full text

Tuneable collagen scaffolds for the directed differentiation of embryonic stem cells towards neural lineages by Monteiro, Gary Albert

“…This thesis aims to develop and understand the role of peptide modified collagen scaffolds in tissue engineering and stem cell differentiation. The…”
Get full text